31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Spermidine is an endogenous biological polyamine that plays various longevity-extending roles and exerts antioxidative, antiaging, and cell growth-promoting effects. We previously reported that spermidine levels were significantly reduced in idiopathic pulmonary fibrosis (IPF) of the lung. The present study assessed the potential beneficial effects of spermidine on lung fibrosis and investigated the possible mechanism. Lung fibrosis was established in mice using bleomycin (BLM), and exogenous spermidine was administered daily by intraperitoneal injection (50 mg/kg in phosphate-buffered saline). BLM-induced alveolar epithelial cells showed significant increases in apoptosis and endoplasmic reticulum stress (ERS)-related mediators, and spermidine attenuated BLM-induced apoptosis and activation of the ERS-related pathway. Senescence-associated β-gal staining and decreased expression of p16 and p21 showed that spermidine ameliorated BLM-induced premature cellular senescence. In addition, spermidine enhanced beclin-1-dependent autophagy and autophagy modulators in IPF fibroblasts and BLM-induced mouse lungs, in which inflammation and collagen deposition were significantly decreased. This beneficial effect was related to the antiapoptotic downregulation of the ERS pathway, antisenescence effects, and autophagy activation. Our findings suggest that spermidine could be a therapeutic agent for IPF treatment.

          Lung fibrosis: Spermidine, anti-aging compound inhibit lung fibrosis in mice

          A natural widely occurring molecule with anti-aging properties may offer a new therapeutic option for patients with idiopathic pulmonary fibrosis(IPF). Sung Woo Park and colleagues from Soonchunhyang University Bucheon Hospital, South Korea, administered the anti-aging compound spermidine to mice with bleomycin-induced lung fibrosis. The team had previously shown that IPF lung express lower levels of spermidine than do healthy individuals. In the current investigations, the researchers demonstrated that treatment of spermidine attenuate inflammation and reduce collagen deposition in mouse lungs. On a molecular level, spermidine limited oxidative stress induced cell death and growth arrest by preventing the build-up of misfolded proteins and by activating pathways for the removal of dysfunctional components from the cell.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          Autophagy in the pathogenesis of disease.

          Autophagy is a lysosomal degradation pathway that is essential for survival, differentiation, development, and homeostasis. Autophagy principally serves an adaptive role to protect organisms against diverse pathologies, including infections, cancer, neurodegeneration, aging, and heart disease. However, in certain experimental disease settings, the self-cannibalistic or, paradoxically, even the prosurvival functions of autophagy may be deleterious. This Review summarizes recent advances in understanding the physiological functions of autophagy and its possible roles in the causation and prevention of human diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The role of senescent cells in ageing.

            Cellular senescence has historically been viewed as an irreversible cell-cycle arrest mechanism that acts to protect against cancer, but recent discoveries have extended its known role to complex biological processes such as development, tissue repair, ageing and age-related disorders. New insights indicate that, unlike a static endpoint, senescence represents a series of progressive and phenotypically diverse cellular states acquired after the initial growth arrest. A deeper understanding of the molecular mechanisms underlying the multi-step progression of senescence and the development and function of acute versus chronic senescent cells may lead to new therapeutic strategies for age-related pathologies and extend healthy lifespan.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

              Little is known about the protein constituents of autophagosome membranes in mammalian cells. Here we demonstrate that the rat microtubule-associated protein 1 light chain 3 (LC3), a homologue of Apg8p essential for autophagy in yeast, is associated to the autophagosome membranes after processing. Two forms of LC3, called LC3-I and -II, were produced post-translationally in various cells. LC3-I is cytosolic, whereas LC3-II is membrane bound. The autophagic vacuole fraction prepared from starved rat liver was enriched with LC3-II. Immunoelectron microscopy on LC3 revealed specific labelling of autophagosome membranes in addition to the cytoplasmic labelling. LC3-II was present both inside and outside of autophagosomes. Mutational analyses suggest that LC3-I is formed by the removal of the C-terminal 22 amino acids from newly synthesized LC3, followed by the conversion of a fraction of LC3-I into LC3-II. The amount of LC3-II is correlated with the extent of autophagosome formation. LC3-II is the first mammalian protein identified that specifically associates with autophagosome membranes.
                Bookmark

                Author and article information

                Contributors
                swpark@schmc.ac.kr
                Journal
                Exp Mol Med
                Exp Mol Med
                Experimental & Molecular Medicine
                Nature Publishing Group UK (London )
                1226-3613
                2092-6413
                14 December 2020
                14 December 2020
                December 2020
                : 52
                : 12
                : 2034-2045
                Affiliations
                [1 ]GRID grid.412678.e, ISNI 0000 0004 0634 1623, Division of Allergy and Respiratory Medicine, Department of Internal Medicine, , Soonchunhyang University Bucheon Hospital, ; 14584 Gyeonggi-Do, South Korea
                [2 ]GRID grid.412678.e, ISNI 0000 0004 0634 1623, Department of Pathology, , Soonchunhyang University Bucheon Hospital, ; 14584 Gyeonggi-Do, South Korea
                Author information
                http://orcid.org/0000-0001-5343-023X
                http://orcid.org/0000-0002-1348-7909
                Article
                545
                10.1038/s12276-020-00545-z
                8080799
                33318630
                95daaf0a-22a1-40b8-98ab-5eaef21a91c6
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 25 August 2020
                : 1 November 2020
                : 3 November 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100003725, National Research Foundation of Korea (NRF);
                Award ID: NRF-2019R1A2C1006351
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Molecular medicine
                immunology,diseases
                Molecular medicine
                immunology, diseases

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content806

                Cited by37

                Most referenced authors1,376